RXO, Inc. (NYSE:RXO) Receives $26.47 Average Price Target from Analysts

Shares of RXO, Inc. (NYSE:RXOGet Free Report) have been given an average recommendation of “Hold” by the seventeen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $26.27.

Several equities analysts have recently issued reports on RXO shares. Citigroup cut RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective for the company. in a research note on Tuesday, November 12th. Susquehanna decreased their price target on shares of RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. The Goldman Sachs Group reiterated a “neutral” rating and set a $29.00 price target on shares of RXO in a report on Monday, November 18th. Oppenheimer restated an “outperform” rating and issued a $31.00 price objective on shares of RXO in a report on Tuesday, September 17th. Finally, Wells Fargo & Company lowered their target price on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research note on Tuesday.

Get Our Latest Report on RXO

Institutional Investors Weigh In On RXO

Hedge funds and other institutional investors have recently modified their holdings of the stock. Wilmington Savings Fund Society FSB acquired a new stake in RXO in the 3rd quarter valued at about $28,000. Nomura Asset Management Co. Ltd. lifted its holdings in shares of RXO by 68.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after purchasing an additional 570 shares in the last quarter. GAMMA Investing LLC grew its position in shares of RXO by 40.0% in the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after purchasing an additional 510 shares during the last quarter. KBC Group NV increased its stake in shares of RXO by 28.1% during the 3rd quarter. KBC Group NV now owns 4,055 shares of the company’s stock worth $114,000 after purchasing an additional 890 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of RXO during the 2nd quarter worth approximately $112,000. 92.73% of the stock is currently owned by institutional investors and hedge funds.

RXO Stock Performance

Shares of RXO stock opened at $25.30 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.33 and a current ratio of 1.33. The firm has a market cap of $4.07 billion, a P/E ratio of -12.78, a P/E/G ratio of 15.82 and a beta of 1.52. The firm’s 50 day moving average price is $27.36 and its 200-day moving average price is $27.83. RXO has a one year low of $18.75 and a one year high of $32.82.

RXO (NYSE:RXOGet Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.01. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. RXO’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.05 EPS. As a group, equities research analysts predict that RXO will post 0.12 EPS for the current year.

RXO Company Profile

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.